Manage Your Liver
Q:

Understanding NAFLD – What are the available diagnosing methods and treatment options?

Understanding NAFLD – What are the available diagnosing methods and treatment options?
A:

Being the leading cause of chronic liver diseases in the USA and Europe, Non-alcoholic Fatty Liver Disease (NAFLD) is gradually becoming a common health issue worldwide. According to a recent research, the global prevalence of NAFLD is estimated to be 24%, with South America and the Middle East having the highest rates of NAFLD patients. 

NAFLD refers to the accumulation of excess fat in the liver of people who only drink little or no alcohol, and there’s a huge correlation between the disease and obesity. Often known as the “silent killer”, NAFLD is difficult to be diagnosed in the early stages because of its asymptomatic nature. 

 

Current diagnosing methods for NAFLD

Since NAFLD does not have much symptoms shown in the early stages, most of the time it is suspected in overweight or obese patients who have mild elevations of liver enzymes in their routine blood tests. Imaging studies such as liver ultrasound can also help diagnose NAFLD by seeing if the patient has accumulation of fat in the liver. 

The most accurate way of detecting NAFLD is a liver biopsy as it provides all the essential information for diagnosis. While it is the most reliable way, doctors don’t usually recommend it since NAFLD is an early stage of liver disease.

In this case, does it mean patients need to wait until when the disease progresses to later stages to be able to do something about it?

 

Possible new biomarker for NAFLD

A recent study conducted by a team of researchers from Britain, Italy, Spain, and France have found that the raised levels of a compound, named phenylacetic acid (PAA) that is released by a certain type of gut bacteria, was linked to the excess fat build-up in the liver and also the early onset of NAFLD. 

The group compared the medical data of 100 women who were diagnosed with NAFLD and obesity but without diabetes with that of a group of healthy individuals and came up with such findings. This research result suggests that PAA could be considered as a new NAFLD biomarker, making early diagnosis of NAFLD just one simple blood test away.

It was also noticed that as NAFLD advanced, the gut microbiome (gut bacteria environment) became poorer and less diverse. While there is definitely a strong link between the development of NAFLD and a poor gut microbiome (raised levels of PAA in this case), it is still unclear which is the cause and which is the effect. But nonetheless, this study definitely opened a new possibility for future clinical research on the early diagnosis of NAFLD by targeting the gut microbiome.

 

Treatments for NAFLD

When NAFLD is not diagnosed or treated, there is a chance of the disease developing into cirrhosis or even liver cancer. Even though not a majority of patients would have their simple fatty liver disease progressed to cirrhosis, patients should always be careful when they are diagnosed with NAFLD. Aside from losing weight, taking natural liver supplements that have proven anti-inflammatory properties can also help bring liver function back to normal, thereby reducing the chance of NAFLD progressing into something much more serious.

 

If you have any questions regarding how we can help restore your liver health, please do not hesitate to contact our support team for more information about liver protection.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
Recently we have received a number of inquiries about the treatment options for fatty liver. After being diagnosed with fatty liver disease, patients are often left with frustration, not sure what they can do to fix this problem. Like in many cases, doctors are unable to offer any clear treatment options apart from diet and exercise.   Why don’t doctors offer any treatment plans? Though fatty liver is common, currently there is still
A:
Fatty liver disease is often found in people with obesity or diabetes. However, people who appear healthy and have a normal weight might also have this problem – have you ever wondered why? Someone could live a healthy lifestyle and don't have any obvious risk factors for NAFLD, but could still have an elevated ALT level (commonly a first indicator of fatty liver disease). Why is it the case? Recent research discovered that our genes are to be blamed.  
Hit Questions
A:
The liver carries out essential functions, including detoxifying harmful substances in your body, cleaning your blood and making new blood and other vital nutrients. Cirrhosis is scarring of the liver caused by long-term liver damage. The loss of liver cells turns into scar tissue which prevents the liver working normally, reducing or in some cases, completely losing liver function. Cirrhosis is a long-term chronic liver damage; it is often caused by chronic live
A:
ALT (Alanine Aminotransferase / SGPT) is a type of enzyme found in liver cells. When the liver cells are functioning normally, the ALT enzymes should be contained within the liver cells.    You can imagine each liver cells as a balloon, and the ALT enzymes are the air inside the balloon. When the balloon is damaged, the air will be released. And when the liver cells is damaged, ALT enzymes are released into the bloodstream, therefore we are able to find out the l
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health.   What does high ALT indicate? ALT enzymes are normally contained within liver cells when the liver is healthy, but when the liver cells are injured or damaged by whatever means, ALT enzymes are released into the bloodstream, causing levels to go up. Therefore, by measuring the
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us
Subscribe To Our Mailing List And
Never Miss Another Great Promotion!
Join our mailing list to receive latest new about our company, plus health articles. You will also be able to receive early bird discount from us!
Maybe Later, Thank you.
Subscribe success! You will receive latest new soon.